Li-Rong Lin

966 total citations
17 papers, 814 citations indexed

About

Li-Rong Lin is a scholar working on Molecular Biology, Nephrology and Epidemiology. According to data from OpenAlex, Li-Rong Lin has authored 17 papers receiving a total of 814 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Nephrology and 5 papers in Epidemiology. Recurrent topics in Li-Rong Lin's work include Chronic Kidney Disease and Diabetes (4 papers), Renal Diseases and Glomerulopathies (4 papers) and Autophagy in Disease and Therapy (4 papers). Li-Rong Lin is often cited by papers focused on Chronic Kidney Disease and Diabetes (4 papers), Renal Diseases and Glomerulopathies (4 papers) and Autophagy in Disease and Therapy (4 papers). Li-Rong Lin collaborates with scholars based in China and United States. Li-Rong Lin's co-authors include Yani He, Jurong Yang, Jun Zhan, Guangyan Cai, Jian‐Guo Zhang, Xiangmei Chen, Kailong Li, Huanzi Dai, Jie Yang and Yuna Tong and has published in prestigious journals such as Nature Communications, American Journal of Physiology-Cell Physiology and American Journal of Physiology-Renal Physiology.

In The Last Decade

Li-Rong Lin

16 papers receiving 804 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Li-Rong Lin China 11 349 240 203 162 143 17 814
Jurong Yang China 11 354 1.0× 366 1.5× 123 0.6× 134 0.8× 120 0.8× 13 890
Weier Qi Australia 23 637 1.8× 306 1.3× 106 0.5× 122 0.8× 88 0.6× 28 1.3k
H. Wu China 15 337 1.0× 230 1.0× 113 0.6× 81 0.5× 248 1.7× 24 820
Jun Matsuda Japan 16 296 0.8× 286 1.2× 129 0.6× 111 0.7× 349 2.4× 34 981
Carole Hénique France 17 355 1.0× 384 1.6× 187 0.9× 52 0.3× 205 1.4× 24 1.1k
Yu Ishimoto Japan 10 346 1.0× 274 1.1× 85 0.4× 79 0.5× 141 1.0× 21 880
Suozhu Shi China 17 411 1.2× 206 0.9× 170 0.8× 56 0.3× 147 1.0× 39 1.1k
Satoshi Minami Japan 16 260 0.7× 207 0.9× 141 0.7× 112 0.7× 373 2.6× 35 1.1k
Jun‐Ya Kaimori Japan 13 326 0.9× 348 1.4× 131 0.6× 117 0.7× 356 2.5× 26 1.1k
Congwei Luo China 16 529 1.5× 272 1.1× 109 0.5× 81 0.5× 69 0.5× 22 1.0k

Countries citing papers authored by Li-Rong Lin

Since Specialization
Citations

This map shows the geographic impact of Li-Rong Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li-Rong Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li-Rong Lin more than expected).

Fields of papers citing papers by Li-Rong Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li-Rong Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li-Rong Lin. The network helps show where Li-Rong Lin may publish in the future.

Co-authorship network of co-authors of Li-Rong Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Li-Rong Lin. A scholar is included among the top collaborators of Li-Rong Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li-Rong Lin. Li-Rong Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Lin, Li-Rong, Zhiwei Jiao, Rui Liang, et al.. (2024). Deaggregation of mutant Plasmodium yoelii de-ubiquitinase UBP1 alters MDR1 localization to confer multidrug resistance. Nature Communications. 15(1). 1774–1774. 6 indexed citations
2.
Lin, Li-Rong, et al.. (2023). A set of urinary peptides can predict early renal damage in primary hypertension. Journal of Hypertension. 41(10). 1653–1660. 5 indexed citations
3.
Liang, Rui, Rui–Xue Xu, Zhiwei Jiao, et al.. (2023). Human ApoE2 protects mice against Plasmodium berghei ANKA experimental cerebral malaria. mBio. 14(6). e0234623–e0234623.
4.
Lin, Li-Rong, et al.. (2022). MicroRNA expression profiles in familial hypertrophic cardiomyopathy with myosin-binding protein C3 (MYBPC3) gene mutations. BMC Cardiovascular Disorders. 22(1). 278–278. 8 indexed citations
5.
6.
Dai, Huanzi, Wei Hu, Li-Rong Lin, et al.. (2020). Tubular decoy receptor 2 as a predictor of prognosis in patients with immunoglobulin A nephropathy. Clinical Kidney Journal. 14(5). 1458–1468. 3 indexed citations
7.
Chen, Jia, Wei Hu, Fei Xiao, et al.. (2019). DCR2, a Cellular Senescent Molecule, Is a Novel Marker for Assessing Tubulointerstitial Fibrosis in Patients with Immunoglobulin A Nephropathy. Kidney & Blood Pressure Research. 44(5). 1063–1074. 10 indexed citations
8.
Yang, Jie, Jia Chen, Li-Rong Lin, et al.. (2018). Preventive effect of Shenkang injection against high glucose-induced senescence of renal tubular cells. Frontiers of Medicine. 13(2). 267–276. 33 indexed citations
9.
Chen, Kehong, Huanzi Dai, Junjie Yuan, et al.. (2018). Optineurin-mediated mitophagy protects renal tubular epithelial cells against accelerated senescence in diabetic nephropathy. Cell Death and Disease. 9(2). 105–105. 122 indexed citations
10.
Zhang, Weiwei, et al.. (2017). Isolation and identification of senescent renal tubular epithelial cells using immunomagnetic beads based on DcR2. Experimental Gerontology. 95. 116–127. 15 indexed citations
11.
Chen, Jia, Weiwei Zhang, Li-Rong Lin, et al.. (2017). Urinary DcR2 is a novel biomarker for tubulointerstitial injury in patients with diabetic nephropathy. American Journal of Physiology-Renal Physiology. 313(2). F273–F281. 18 indexed citations
12.
Lin, Li-Rong, Jurong Yang, Jian‐Guo Zhang, et al.. (2016). Nocturnal and Circadian Rhythm of Blood Pressure Is Associated with Renal Structure Damage and Function in Patients with IgAN. Archives of Medical Research. 47(1). 25–32. 10 indexed citations
13.
Yang, Jurong, et al.. (2015). Diagnostic value of serum procalcitonin for acute pyelonephritis in infants and children with urinary tract infections: an updated meta-analysis. World Journal of Urology. 34(3). 431–441. 26 indexed citations
14.
Liu, Jun, Jurong Yang, Xiangmei Chen, et al.. (2015). Impact of ER stress-regulated ATF4/p16 signaling on the premature senescence of renal tubular epithelial cells in diabetic nephropathy. American Journal of Physiology-Cell Physiology. 308(8). C621–C630. 101 indexed citations
15.
16.
Yang, Jurong, Jian‐Guo Zhang, Zhiyong Ji, et al.. (2013). Ischemia-reperfusion induces renal tubule pyroptosis via the CHOP-caspase-11 pathway. American Journal of Physiology-Renal Physiology. 306(1). F75–F84. 183 indexed citations
17.
Liu, Jun, Yani He, Guangyan Cai, et al.. (2011). Accelerated senescence of renal tubular epithelial cells is associated with disease progression of patients with immunoglobulin A (IgA) nephropathy. Translational research. 159(6). 454–463. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jurong Yang Breakdown of academic impact, for papers by Weier Qi Breakdown of academic impact, for papers by H. Wu Breakdown of academic impact, for papers by Jun Matsuda Breakdown of academic impact, for papers by Carole Hénique Breakdown of academic impact, for papers by Yu Ishimoto Breakdown of academic impact, for papers by Suozhu Shi Breakdown of academic impact, for papers by Satoshi Minami Breakdown of academic impact, for papers by Jun‐Ya Kaimori Breakdown of academic impact, for papers by Congwei Luo
Rankless by CCL
2026